idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
WNT messenger proteins are crucial for a variety of cellular functions. A specific WNT messenger can increase muscle mass and improve regeneration in skeletal muscle. This makes them promising candidates for the treatment of diseases associated with muscular atrophy. Unfortunately, their enormous size and “stickiness,” hampered therapeutic applications so far. Researchers at the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena and the BTU Cottbus-Senftenberg now demonstrated that even a small part of this messenger substance is sufficient to mediate its full function. This could solve the problems of therapeutic application.
Jena/Cottbus-Senftenberg. WNT signaling is crucial for the development of organisms and the maintenance of tissue homeostasis, since the WNT messengers are involved in a variety of cellular functions. In skeletal muscle, for example, they can increase muscle mass and improve regeneration. This is an important entry point for therapies to treat diseases associated with reduced muscle mass, such as cachexia. Despite this promising potential, until now it has been difficult to use the potential of these molecules in practice: the messenger proteins, which consist of more than 400 amino acids, are very large and “sticky” – meaning, they show poor dispersal in the tissue, which makes medical application difficult. Furthermore, little is known about the functional relevance of the different structural areas in the individual WNT proteins.
The research group “Stem Cells of Skeletal Muscle” led by Prof. Julia von Maltzahn from the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena and the Faculty of Health Sciences at the BTU Cottbus-Senftenberg in Senftenberg, has now demonstrated in a recent study, that even a small component of the messenger protein WNT7A is sufficient to activate the same signaling pathways in muscle cells which can be activated by the complete protein. The study was recently published in the Computational and Structural Biotechnology Journal (Open Access).
Which areas are important for WNT signal transmission?
“So far, very little is known about the importance and functional relevance of the different areas in WNT proteins, especially about the binding sites to the receptors in recipient cells,” reports Prof. Julia von Maltzahn. “Therefore, we specifically investigated the C-terminus of WNT7A, as this region contains both a hairpin and a linker region and is shows full functionality.”
Hairpin region is sufficient to promote muscle growth
The researchers found that treatment with small protein fragments, the C-terminal WNT7A variants containing only the hairpin region, is sufficient to trigger the same cellular signaling pathways in muscle cells that are activated by the complete WNT7A protein. The extracellular messenger WNT7A influences the signaling pathway for muscle growth and the renewal of muscle stem cells. This stimulates the growth of muscle fibers and promotes proliferation and distribution of muscle stem cells in skeletal muscle, for example after injury.
Will it soon be possible to treat muscular atrophy with tiny messenger fragments?
“Our results demonstrated, that tiny messenger fragments, consisting of only the hairpin region, make the development of a WNT7A-based therapy for various muscle wasting conditions, such as cancer cachexia, more feasible,” explains Dr. Manuel Schmidt, postdoc in the research group and lead author of the publication.
In previous studies, the Jena scientists had already shown that WNT7A increases muscle mass and the division of muscle stem cells in mice suffering from cachexia, a muscle-wasting syndrome that affects a large proportion of cancer patients. The WNT proteins were subsequently targeted by researchers as promising candidates for therapeutic interventions to address muscle-wasting diseases such as muscular dystrophy and cancer cachexia, but the molecules’ considerable size and poor manageability prevent their use as a therapeutic agent.
A wide range of possible applications
The shorter variant of the protein could now solve this problem. Thanks to its small size, the extracellular messenger WNT7A seems to be better suited for therapeutic use. Possible applications include supportive therapies for the loss of muscle mass due to cancer or as a stimulus for muscle regeneration after surgery. This is due to the fact that WNT7A promotes an increase of stem cells in the muscle and thus supports muscle regeneration after injuries or surgeries.
The work was funded by the German Research Foundation (DFG) and the German Cancer Aid Foundation (Deutsche Krebshilfe) and supported by the SPARK-FLI technology transfer program at the institute. Dr. Sonja Schätzlein, head of SPARK-FLI, considers the research results an initial success: “I am very pleased that through our financial support, advice, and provision of mentoring partners from industry, SPARK-FLI was able to help advance this project an important step towards a medical therapy. I eagerly look forward to seeing further results.”
Publication
Schmidt M, Poser C, Janster C, von Maltzahn J. The hairpin region of WNT7A is sufficient for binding to the Frizzled7 receptor and to elicit signaling in myogenic cells. Computational and Structural Biotechnology Journal. 2022, 20, 6348-6359. DOI: 10.1016/j.csbj.2022.10.047.
https://www.sciencedirect.com/science/article/pii/S2001037022004949
Information on SPARK-FLI
The “Counteracting Cancer Cachexia” project was supported from 2018–2020 by SPARK-FLI. The internal technology transfer program SPARK-FLI helps to transfer fundamental scientific findings from biomedical research into diagnostics or medical applications and ensures that government-funded research contributes to the improved health of our society. This targeted funding not only increases the chances of success of the respective research project, but also reduces the costs as well as the time required to achieve its aims.
Contact
Dr. Kerstin Wagner
Press and Public Relations
Phone: 03641-656378, email: presse@leibniz-fli.de
+++++++++++++++
Background information
The Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) – upon its inauguration in 2004 – was the first German research organization dedicated to research on the process of aging. More than 350 employees from around 40 nations explore the molecular mechanisms underlying aging processes and age-associated diseases. For more information, please visit http://www.leibniz-fli.de.
The Leibniz Association connects 97 independent research institutions that range in focus from natural, engineering and environmental sciences to economics, spatial and social sciences and the humanities. Leibniz Institutes address issues of social, economic and ecological relevance. They conduct basic and applied research, including in the interdisciplinary Leibniz Research Alliances, maintain scientific infrastructure, and provide research-based services. The Leibniz Association identifies focus areas for knowledge transfer, particularly with the Leibniz research museums. It advises and informs policymakers, science, industry and the general public. Leibniz institutions collaborate intensively with universities – including in the form of Leibniz ScienceCampi – as well as with industry and other partners at home and abroad. They are subject to a transparent, independent evaluation procedure. Because of their importance for the country as a whole, the Leibniz Association Institutes are funded jointly by Germany’s central and regional governments. The Leibniz Institutes employ around 20,500 people, including 11,500 researchers. The financial volume amounts to 2 billion euros. For more information: http://www.leibniz-gemeinschaft.de/en/.
Schmidt M, Poser C, Janster C, von Maltzahn J. The hairpin region of WNT7A is sufficient for binding to the Frizzled7 receptor and to elicit signaling in myogenic cells. Computational and Structural Biotechnology Journal. 2022, 20, 6348-6359. DOI: 10.1016/j.csbj.2022.10.047.
https://www.sciencedirect.com/science/article/pii/S2001037022004949
In skeletal muscle, the WNT7A protein can increase muscle mass. Until now, therapeutic application h ...
Image: FLI / Kerstin Wagner, created with BioRender.com
Merkmale dieser Pressemitteilung:
Journalisten, Wissenschaftler, jedermann
Biologie, Chemie, Ernährung / Gesundheit / Pflege, Medizin
überregional
Forschungsergebnisse, Wissenschaftliche Publikationen
Englisch
In skeletal muscle, the WNT7A protein can increase muscle mass. Until now, therapeutic application h ...
Image: FLI / Kerstin Wagner, created with BioRender.com
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
